Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Hematologic Malignancies Detection Market Growth Performance Trended Historically, And What Lies Ahead?
The market size for detecting hematologic malignancies has experienced swift expansion in the last few years. Forecasts predict an increase from $2.68 billion in 2024 to $3.1 billion in 2025, representing a compound annual growth rate (CAGR) of 15.6%. Factors contributing to the growth during the historic period include a higher rate of diagnosed conditions, greater public consciousness of their significance, augmenting demand from patients, encouraging regulatory structures, and the proliferation of digital health technology.
What Is the Forecast for the Hematologic Malignancies Detection Market Size Through 2029?
In the years to come, a swift expansion in the hematologic malignancies detection market size is anticipated. The market is expected to rise to $5.46 billion by 2029, with a compound annual growth rate (CAGR) of 15.2%. The growth predicted in this period can be associated with the extension of healthcare infrastructure, government measures and funding, an expansion in health insurance coverage, and betterments in data management systems. Key tendencies during the predicted period include improved genetic and epigenetic data resolution, innovative methods for profiling protein expressions, advanced immunoassay techniques, the formulation of nanomaterials and nano sensors, and the growth of telemedicine platforms.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19504&type=smp
What are the Key Market Players in Hematologic Malignancies Detection Market and How They’re Evolving?
Major companies operating in the hematologic malignancies detection market are AbbVie Inc., Sanofi-Aventis U.S LLC, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Novartis AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings, ICON plc, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Kite Pharma Inc., ArcherDx Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Tempus Labs Inc., Adaptive Biotechnologies Corporation, Freenome Inc., Invivoscribe Technologies Inc., Asuragen Inc., Celldex Therapeutics Inc.
What Are the Primary Growth Drivers in the Hematologic Malignancies Detection Market?
The escalating occurrence of blood cancer is projected to drive the expansion of the hematologic malignancy detection market in the future. Blood cancer is a collection of cancers that affect the blood, bone marrow, or the lymphatic system, and interferes with the normal production and function of blood cells. The rise in blood cancer cases can be attributed to factors such as an aging population and enhanced diagnostic methodologies that facilitate swifter and more precise detection. Detection of hematologic malignancy is crucial for treating blood cancer as it ensures prompt and exact diagnosis, thereby paving the way for individualized and effective treatment plans. For instance, a Cancer Facts & Figures 2023 report by the Leukemia & Lymphoma Society, a professional organization from US, revealed in March 2024 that nearly 437,337 people in the US are currently living with or have recovered from leukemia. Moreover, there are approximately 59,610 new cases anticipated to be identified in 2024. Hence, the rising occurrence of blood cancer serves as a major contributing factor for the growth of the hematologic malignancy detection market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=19504&type=smp
What Are the Leading Segments in the Global Hematologic Malignancies Detection Industry?
The hematologic malignancies detectionmarket covered in this report is segmented –
1) By Type: Polymerase Chain Reaction, Immunochemistry, Next Generation Sequencing, Fluorescence In Situ Hybridization, Other Types
2) By Application: Multiple Myeloma, Myelodysplastic Syndrome, Leukemia, Myeloproliferative Neoplasms, Lymphoma, Other Application
3) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Polymerase Chain Reaction (PCR): Real-Time PCR (qPCR), Digital PCR, Reverse Transcription PCR (RT-PCR), Nested PCR, Multiplex PCR, PCR-Based Detection Kits
2) By Immunochemistry: Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry (IHC), Western Blotting, Flow Cytometry, Immunofluorescence, Immunohistochemical Staining Kits
3) By Next Generation Sequencing (NGS): Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing, RNA Sequencing (RNA-Seq), Liquid Biopsy NGS, Next-Generation Sequencing Kits For Hematologic Malignancies
4) By Fluorescence In Situ Hybridization (FISH): Chromosome-Specific FISH Probes, DNA FISH, RNA FISH, Multicolor FISH, FISH-Based Detection Kits For Leukemia And Lymphoma
5) By Other Types: Cytogenetic Testing, Cytometry-Based Detection, Magnetic Resonance Imaging (MRI) For Detection, High-Performance Liquid Chromatography (HPLC), Mass Spectrometry For Hematologic Malignancies Detection
What Are the Key Market Trends in the Hematologic Malignancies Detection Industry?
Key players in the hematologic malignancy detection market are prioritizing the creation of innovative solutions, like tests for blood cancer diagnosis, to increase diagnostic precision and better patient results. These tests are vital for discovering and validating hematologic malignancies such as leukemia, lymphoma, and multiple myeloma. For instance, in November 2023, Roswell Park Comprehensive Cancer Center, a US research and treatment institution, initiated PanHeme, a cutting-edge diagnostic test for blood cancer that leverages next-gen gene sequencing technology for detecting hematologic malignancy. With the use of this next-gen sequencing, PanHeme can pinpoint genetic aberrations in blood cancers like leukemia, lymphoma, and multiple myeloma in less than 72 hours, considerably more efficient than conventional means. This expedited process facilitates personalized treatment approaches by enabling medical practitioners to apply targeted FDA-approved treatments based on specific genetic mutations.
Access The Full Report Here:
What Is the Regional Outlook for the Hematologic Malignancies Detection Market?
North America was the largest region in the hematologic malignancies’ detection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hematologic malignancies detection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19504
This Report Delivers Insight On:
1. How big is the hematologic malignancies detection market, and how is it changing globally?
2. Who are the major companies in the hematologic malignancies detection market, and how are they performing?
3. What are the key opportunities and risks in the hematologic malignancies detection market right now?
4. Which products or customer segments are growing the most in the hematologic malignancies detection market?
5. What factors are helping or slowing down the growth of the hematologic malignancies detection market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
